Skip to Main Content

Personalized Prevention: Smoking Cessation in Patients With a Lung Nodule

Conditions

Lung

Phase III

What is the purpose of this trial?

The purpose of this study is to test the efficacy of two separate, sequential interventions to promote tobacco cessation/reduction in individuals recently identified with lung nodules. Each intervention will be compared to standard of care. The first intervention will be a personalized message intervention, the second intervention will consist of a biofeedback-based intervention.

  • Trial with
    Department of Health & Human Services
  • Start Date
    06/28/2016
  • End Date
    05/31/2025
Trial Image

For more information about this study, contact:

Susan Neveu

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    06/22/2018
  • Study HIC
    #1505015965